1
The Cost of Pharmacovigilance

The Cost of Pharmacovigilance

No time to read now? -> Download the article as a handy pdf List of contents Introduction Summary Authority costs and service fees Company costs Quality costs Money is the reason EMA administrative costs Cost of PV to the pharmaceutical industry Performance...
How is this still a thing? Internet Explorer for EVWEB

How is this still a thing? Internet Explorer for EVWEB

No time to read now? -> Download the article as a handy pdf List of contents Familiar sight? The browser from the past Retirement in 2022 How is this still a thing? Internet Explorer for EVWEB Martti’s ramblings about the nearly mandatory use of outdated software...
Do PV Activities Today Really Save Lives? Part II

Do PV Activities Today Really Save Lives? Part II

No time to read now? -> Download the article as a handy pdf List of contents Introduction The Background The Data from Eurostat Data Analysis Adverse events Adverse events / poisoning ADRs, poisoning and anonymized causes Conclusion Do PV Activities Today Really...
Do PV Activities Today Really Save Lives?

Do PV Activities Today Really Save Lives?

No time to read now? -> Download the article as a handy pdf List of contents Introduction TLDR Background Impact Assessment Pharmacoeconomics of ADRs Incidence of ADRs in Hospitalized Patients Extrapolation and Outdated Information Hospitalization and Deaths Caused...
Is Local Literature Screening Really Necessary? Part II

Is Local Literature Screening Really Necessary? Part II

No time to read now? -> Download the article as a handy pdf List of contents Introduction Response from the EMA Our response to the EMA LLS is not cost-effective Current options We need a better solution References Is Local Literature Screening Really Necessary?...